Loading...

Industry News

SynBioBeta brings you the latest news weekly to help you stay informed and learn about the latest developments in the synthetic biology industry. Subscribe to receive the latest news weekly to your inbox. Have news to share? Contact us to submit your story.

Subscribe

Stay Updated on the Latest News in Synthetic Biology

Subscribe to the Weekly SynBioBeta Digest
Subscribe

Latest News

March 2017

Why the UK is a Great Place to Start a Synthetic Biology Company

GENEWIZ to Launch Single-Cell RNA-Seq Services At AACR

SGI-DNA Launches Automated Next-Generation Sequencing Library Construction Kits for the BioXp™ 3200 System to Expand the Capabilities of the Genomic Workstation

CRISPR Therapeutics Announces European Patent for CRISPR/Cas Gene Editing

Twist Bioscience Raises $33 Million

DEINOVE enters the cosmetic ingredients market with GREENTECH with the objective of a commercial launch by end of 2018

Meet These French SynBio Startups and Organizations

GenScript Partners With iGEM to Expand Synthetic Biology Community in China

BASF licenses CRISPR-Cas9 genome-editing technology from the Broad Institute

Lightning Talks at SynBioBeta London will Showcase International Synbio Scene

Cell Design Labs Announces Issuance of Broad Patent for Programmable Car-T Cells to Treat Cancer and Other Diseases

AgriMetis Announces Publication of Spinosyn Analog Patent Applications

DEINOVE now has a catalog of active extracts identified for cosmetic applications

How DARPA is Leading the Debate on Biosecurity and Biosafety With Genome Editors

Zio Fungicide, Developed by AgBiome, Receives EPA Registration

Synthego Announces Modified Synthetic sgRNA for CRISPR Genome Editing

Intrexon CEO RJ Kirk to Speak at SB7.0

eGenesis Co-Founder Luhan Yang Named Young Global Leader by World Economic Forum

eGenesis Announces $38 Million Series A Financing, Led by Biomatics Capital and ARCH Venture Partners, to Solve Shortage of Organs for Donation

Editas Medicine, Inc. Announces Pricing of $90 Million Offering of Common Stock